Table 1.
Parameters | Survivors (n = 34) |
Non-Survivors (n = 20) |
p Value |
---|---|---|---|
Gender (W/M) | 21/13 | 5/15 | 0.002 * |
Age (years) | 54.06 ± 12.43 | 62.9 ± 14.18 | 0.020 * |
BMI (kg/m2) | 28.24 ± 4.60 | 27.88 ± 4.05 | 0.903 |
Obesity prevalence (%) | 52.17 | 41.66 | 0.277 |
T2D prevalence (%) | 43.47 | 75.00 | 0.037 * |
Hypertension prevalence (%) | 17.39 | 58.33 | 0.006 * |
Coronary heart disease (%) | 8.69 | 33.33 | 0.033 * |
IMV (%) | 30.43 | 83.33 | 0.001 * |
Time to extubation (days) | 2.43 ± 0.79 | 3.66 ± 0.82 | 0.167 |
Inpatient days (days) | 15.65 ± 3.13 | 8.41 ± 1.66 | 0.060 |
Drug regimen | Aziythromycin, ceftriaxone, enoxaparin sodium, dexamethasone, and acetaminophen | - |